Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine

This publication has 25 references indexed in Scilit:

• Meningococcal serogroup C-specific IgG antibody responses and serum bactericidal titres in children following vaccination with a meningococcal A/C polysaccharide vaccine
  FEMS Immunology & Medical Microbiology, 2000
• Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2–3 and 7–8 years of age
  Vaccine, 2000
• Human IgG subclass responses in relation to serum bactericidal and opsonic activities after immunization with three doses of the Norwegian serogroup B meningococcal outer membrane vesicle vaccine
  Vaccine, 1999
• Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine
  Vaccine, 1996
• Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine
  Vaccine, 1996
• Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile
  Vaccine, 1995
• Laboratory Correlates of Protection against Haemophilus influenzae Type b Disease
  Annals of the New York Academy of Sciences, 1995
• Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil
  The Lancet, 1992
• Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway
  The Lancet, 1991
• Human IgG subclass pattern of inducing complement‐mediated cytolysis depends on antigen concentration and to a lesser extent on epitope patchiness, antibody affinity and complement concentration
  European Journal of Immunology, 1991